Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TPT1 pseudogene 1 (TPT1P1) is a processed pseudogene within the human genome. Processed pseudogenes are DNA sequences generated from retrotransposed mRNA of ancestral genes and typically lack functional coding capacity. TPT1P1 shares sequence similarity with the functional TPT1 gene but does not encode a functional protein and does not exhibit known biological function or involvement in human disease, nor is it relevant as a therapeutic drug target[6]. Summary: TPT1P1 is a nonfunctional pseudogene and not a therapeutic target. Canonical scientific data classifies it solely as a genomic sequence with no protein product, no known biological function, and no relevance as a disease or drug target. For target annotation, this entry is incorrect as a therapeutic target and should not be used for drug development, mechanism-of-action mapping, or biomarker analysis[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TPT1 pseudogene 1 (TPT1P1).